Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (32 ops.)
Latest filing published 25 Sept 2026 for NEKTAR THERAPEUTICS. Read the official filing
Filing timeline
BuySaleDiana Brainard
Insider track record
Disclosed buys
0
Disclosed sells
32
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Diana Brainard: trading record in brief
Filings by Diana Brainard span 2 companies, the busiest being Kalaris Therapeutics, Inc. and Nektar Therapeutics. Over a trading history stretching from 17 May 2021 to 23 September 2026, the count stands at 40 filings.
The open-market record consists of 32 sales worth €618k, with no purchase. Outside the open market, there are 8 share grants.
On 25 September 2026 came the latest disclosure, a share grant in Nektar Therapeutics. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Diana Brainard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
2,000 shares0Common StockSEC:0001193125-26-403099:0
8,706 shares@ US$0.54850.7% of flowCommon StockSEC:0000950170-24-129257:0
10,609 shares@ US$0.86491.4% of flowCommon StockSEC:0000950170-24-122336:0
9,752 shares@ US$0.7791.1% of flowCommon StockSEC:0000950170-24-116645:0
1,493 shares@ US$0.81480.2% of flowCommon StockSEC:0000950170-24-112912:0
5,390 shares@ US$0.74130.6% of flowCommon StockSEC:0000950170-24-099846:0
3,091 shares@ US$0.75950.3% of flowCommon StockSEC:0000950170-24-099102:0
10,847 shares@ US$0.73481.2% of flowCommon StockSEC:0000950170-24-092807:0
9,731 shares@ US$0.75011.1% of flowCommon StockSEC:0000950170-24-085669:0
1,489 shares@ US$0.720.2% of flowCommon StockSEC:0000950170-24-081511:0
5,149 shares@ US$0.79230.6% of flowCommon StockSEC:0000950170-24-064052:0
3,075 shares@ US$0.74930.3% of flowCommon StockSEC:0000950170-24-062982:0
10,240 shares@ US$0.7961.2% of flowCommon StockSEC:0000950170-24-054512:0
9,601 shares@ US$0.75061.1% of flowCommon StockSEC:0000950170-24-046908:0
1,533 shares@ US$0.7720.2% of flowCommon StockSEC:0000950170-24-041810:0
3,097 shares@ US$0.69520.3% of flowCommon StockSEC:0000950170-24-018785:0
41,421 shares@ US$0.674.2% of flowCommon StockSEC:0000950170-24-011769:0
9,500 shares@ US$0.67040.9% of flowCommon StockSEC:0000950170-24-007406:0
1,664 shares@ US$0.6390.2% of flowCommon StockSEC:0000950170-24-002935:0
2,689 shares@ US$1.63110.7% of flowCommon StockSEC:0001209191-23-056313:0
4,382 shares@ US$1.69051.1% of flowCommon StockSEC:0001209191-23-056313:1
8,581 shares@ US$1.582.1% of flowCommon StockSEC:0001209191-23-053349:0
1,325 shares@ US$1.97630.4% of flowCommon StockSEC:0001209191-23-052229:0
11,361 shares@ US$2.49554.2% of flowCommon StockSEC:0001209191-23-046732:0
8,342 shares@ US$3.56154.3% of flowCommon StockSEC:0001209191-23-043121:0
25 of 40 declarations
